Skip to main content
. Author manuscript; available in PMC: 2009 Oct 1.
Published in final edited form as: Cell Cycle. 2008 Oct 7;7(19):2949–2955. doi: 10.4161/cc.7.19.6760

Figure 4. Expression of IGF components in WT and mutant GISTs by immunohstochemistry (IHC).

Figure 4

IGF-1R, IGF-1, IGF-2 and KIT expression in WT and mutant GISTs as analyzed by IHC. Primary antibodies used include IGF-2 (1:500 dilution, Abcam), IGF-1R (1:50 dilution, Cell Signaling) and KIT (1:2000 dilution, Dako).